Literature DB >> 17217159

Calciphylaxis: evolving concepts.

Giovanni Garini, Elisa Galletti, Roberto Ricci, Augusto Vaglio, Carlo Buzio.   

Abstract

Mesh：

Year:  2006        PMID： 17217159     DOI： 10.1007/BF02934772

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  15 in total

Review 1.  The evolving pattern of calciphylaxis: therapeutic considerations.

Authors:  F Llach
Journal:  Nephrol Dial Transplant       Date:  2001-03       Impact factor: 5.992

2.  Calcific uremic arteriolopathy (calciphylaxis): an evolving entity?

Authors:  F Llach
Journal:  Am J Kidney Dis       Date:  1998-09       Impact factor: 8.860

Review 3.  Regulation of vascular calcification: roles of phosphate and osteopontin.

Authors:  Cecilia M Giachelli; Mei Y Speer; Xianwu Li; Rupak M Rajachar; Hsueh Yang
Journal:  Circ Res       Date:  2005-04-15       Impact factor: 17.367

4.  Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.

Authors:  Peter Stenvinkel; Kai Wang; Abdul Rashid Qureshi; Jonas Axelsson; Roberto Pecoits-Filho; Ping Gao; Peter Barany; Bengt Lindholm; Tomas Jogestrand; Olof Heimbürger; Clifford Holmes; Martin Schalling; Louise Nordfors
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

5.  Cutaneous calciphylaxis. An underrecognized clinicopathologic entity.

Authors:  L R Essary; M R Wick
Journal:  Am J Clin Pathol       Date:  2000-02       Impact factor: 2.493

6.  Risk factors and mortality associated with calciphylaxis in end-stage renal disease.

Authors:  A R Mazhar; R J Johnson; D Gillen; J C Stivelman; M J Ryan; C L Davis; C O Stehman-Breen
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

7.  Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells.

Authors:  S Ahmed; K D O'Neill; A F Hood; A P Evan; S M Moe
Journal:  Am J Kidney Dis       Date:  2001-06       Impact factor: 8.860

8.  Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy.

Authors:  Adrian Fine; James Zacharias
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

9.  Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

Authors:  Markus Ketteler; Philipp Bongartz; Ralf Westenfeld; Joachim Ernst Wildberger; Andreas Horst Mahnken; Roland Böhm; Thomas Metzger; Christoph Wanner; Willi Jahnen-Dechent; Jürgen Floege
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

10.  The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.

Authors:  Cora Schafer; Alexander Heiss; Anke Schwarz; Ralf Westenfeld; Markus Ketteler; Jurgen Floege; Werner Muller-Esterl; Thorsten Schinke; Willi Jahnen-Dechent
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808
View more
  1 in total

1.  Suspected systemic calcinosis and calciphylaxis in 5 horses.

Authors:  Jean-Yin Tan; Stephanie J Valberg; Manu M Sebastian; Gordon D Davis; Jenny R Kelly; Lutz S Goehring; Malte M Harland; K Leann Kuebelbeck; Bryan M Waldridge; Joseph C Newton; Johanna M Reimer
Journal:  Can Vet J       Date:  2010-09       Impact factor: 1.008
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.